Artigo

Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged ≥90 Years: A Large Retrospective Cohort Study

Autor(es): Massimo Ferrucci, MD, PhD1, Daniele Passeri, MD2, Francesco Milardi, MD2, Andrea Francavilla, MD3, Matteo Cagol, MD1, Mariacristina Toffanin, MD1, Giacomo Montagna, MD, MPH4, and Alberto Marchet, MD1

ABSTRACT

Background: The population aged ≥90 years is increasing worldwide, yet nearly 50% of elderly breast cancer (BC) patients receive suboptimal treatments, resulting in high rates of BC-related mortality. We analyzed clinical and survival outcomes of nonagenarian BC patients to identify effective treatment strategies.

Methods: This single-institution retrospective cohort study analyzed patients aged ≥90 years diagnosed with stage I–III BC between 2007 and 2018. Patients were categorized into three treatment groups: traditional surgery (TS), performed according to local guidelines; current-standard surgery (CS), defined as breast surgery without axillary surgery (in concordance with 2016 Choosing Wisely guidelines) and/ or cavity shaving; and non-surgical treatment (NS). Clinicopathological features were recorded and recurrence rates and survival outcomes were analyzed.

Results: We collected data from 113 nonagenarians with a median age of 93 years (range 90–99). Among these patients, 43/113 (38.1%) underwent TS, 34/113 (30.1%) underwent CS, and 36/113 (31.9%) underwent NS. The overall recurrence rate among surgical patients was 10.4%, while the disease progression rate in the NS group was 22.2%. Overall survival was significantly longer in surgical patients compared with NS patients (p = 0.04). BC-related mortality was significantly higher in the NS group than in the TS and CS groups (25.0% vs. 0% vs. 7.1%, respectively; p = 0.01). There were no significant differences in overall survival and disease-free survival between the TS and CS groups (p = 0.6 and p = 0.8, respectively), although the TS group experienced a significantly higher overall postoperative complication rate (p < 0.001).

Conclusions: Individualized treatment planning is essential for nonagenarian BC patients. Surgery, whenever feasible, remains the treatment of choice, with CS emerging as the best option for the majority of patients.

Keywords: Breast cancer · Elderly patients · Breast surgery · Axillary surgery · Geriatric assessment · Nonagenarians

Compartilhar em:

Compartilhar em:

Kit-MKT-Breast-Breaking-NewsAvatar
Breast Breaking News
04/08/2024

Comentários

Deixe um comentário

0

Conteúdos Relacionados

Comentários

Deixe um comentário

Carrinho de compras